Paul Knight
Stock Analyst at Keybanc
(1.86)
# 3,265
Out of 5,150 analysts
139
Total ratings
45.22%
Success rate
-2.61%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $512.69 | +46.29% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $248.84 | +40.65% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $3.59 | +317.83% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.06 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $137.04 | +60.54% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $8.74 | +71.62% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.57 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $57.85 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $319.04 | +44.18% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.06 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $4.36 | +83.49% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $98.49 | +47.22% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $173.21 | +142.48% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $108.74 | +111.51% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $20.67 | +59.65% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $28.17 | +27.80% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $204.73 | +51.42% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $125.84 | +74.83% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $17.50 | +111.43% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.82 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $2.34 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $120.54 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $25.13 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $8.65 | +362.43% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $179.58 | +67.06% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $177.88 | +40.54% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $119.18 | +270.03% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $142.46 | +65.66% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $81.98 | +20.76% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $13.88 | +296.25% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $36.27 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $92.94 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $128.97 | - | 5 | Oct 23, 2017 |
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $512.69
Upside: +46.29%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $248.84
Upside: +40.65%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $3.59
Upside: +317.83%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.06
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $137.04
Upside: +60.54%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $8.74
Upside: +71.62%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.57
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $57.85
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $319.04
Upside: +44.18%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.06
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $4.36
Upside: +83.49%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $98.49
Upside: +47.22%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $173.21
Upside: +142.48%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $108.74
Upside: +111.51%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $20.67
Upside: +59.65%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $28.17
Upside: +27.80%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $204.73
Upside: +51.42%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $125.84
Upside: +74.83%
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $17.50
Upside: +111.43%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.82
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $2.34
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $120.54
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $25.13
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $8.65
Upside: +362.43%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $179.58
Upside: +67.06%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $177.88
Upside: +40.54%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $119.18
Upside: +270.03%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $142.46
Upside: +65.66%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $81.98
Upside: +20.76%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $13.88
Upside: +296.25%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $36.27
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $92.94
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $128.97
Upside: -